Bio-Path Holdings Announces Collaboration With Thomas Jefferson University for Systemic Antisense Immunotherapy Treatment for Brain Cancer

BPTH_TJU_PR_20160628

Leave a Reply

Your email address will not be published. Required fields are marked *